Brand-name medicines can be more expensive than the generic version because the companies that produce brand-name versions often invest more money into discovery, development, and/or marketing the ...

Intellectual property (IP) rights secured through patents facilitate the introduction of dozens of new brand-name drugs and hundreds of generic drugs annually in the United States. However, proposals ...

Health Canada is supposed to issue rulings on new generics – which are copies of branded drugs whose patents have expired – ...

This testing can make the drugs expensive. The manufacturer of a brand-name drug can sell the drug exclusively for up to 20 years. After that, other drugmakers can create generic versions.

Brand-name drugs can be expensive because of the research needed to test their safety and effectiveness. The manufacturer of a brand-name drug can sell it for up to 20 years.

Other drugs on the list include generics of the cholesterol-lowering drug Lipitor from India's Lupin Ltd and risendronate sodium from Aurobindo Pharma Ltd. Lupin sold 25 million generic Lipitor ...

A generic drug, like the liraglutide generic approved Monday, is a copy of a brand-name drug developed and made by another company. “Generic drugs provide additional treatment options which are ...